论文部分内容阅读
现将我院对收治的40例尿毒症患者血液透析前、后血脂变化及水平进行检测报道如下。 1 对象与方法 1.1 对象 ①正常组:40例健康人,男25例,女15例,平均年龄(50.3±8.2)岁,经临床检查除外高血压及冠心病;②透析组:40例均为我院晚期尿毒症维持血液透析患者,慢性肾炎29例,梗阻性肾病8例,糖尿病肾病3例,男24例,女16例,平均年龄(53.1±13.3)岁,全部患者未用影响血脂的药物。 1.2 血透方法 采用Batter-550型血液透析机,中空醋酸纤维膜透析器,并用碳酸氢盐透析液透析,反渗水处理,患者每周透析1~3次,每次3~4小时,以肝素抗凝,首剂量2000U,以每小时1200U维持至透析前30分钟。
Now in our hospital admitted 40 cases of uremic patients before and after hemodialysis, blood lipid changes and levels were reported as follows. 1 object and method 1.1 object ① normal group: 40 healthy people, 25 males and 15 females, the average age (50.3 ± 8.2) years old, except for clinical examination of hypertension and coronary heart disease; dialysis group: 40 cases were There were 29 cases of chronic nephritis, 8 cases of obstructive nephropathy, 3 cases of diabetic nephropathy, 24 males and 16 females, with an average age of (53.1 ± 13.3) years old, all of whom had no effect on blood lipids drug. 1.2 hemodialysis method using Batter-550 hemodialysis machine, hollow acetate fiber dialyzer, dialysis with bicarbonate dialysis, reverse osmosis treatment, the patient dialysis 1 to 3 times a week, each 3 to 4 hours to heparin Anticoagulant, the first dose of 2000U, 1200U per hour to maintain dialysis before 30 minutes.